Last update 01 Jun 2025

Tricaprylin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Caprylic acid triglyceride, Caprylic triglyceride, Glycerol tricaprylate
+ [14]
Target-
Action-
Mechanism-
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (01 Jan 1993),
RegulationOrphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H50O6
InChIKeyVLPFTAMPNXLGLX-UHFFFAOYSA-N
CAS Registry538-23-8

External Link

KEGGWikiATCDrug Bank
-Tricaprylin

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alzheimer Disease
United States
-01 Jan 1993
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 2
United States
15 Jul 2022
Migraine DisordersPhase 2
Australia
17 Dec 2020
AmnesiaPhase 2
United States
01 Jul 2006
EpilepsyPhase 1
United States
15 Jul 2022
Spasms, InfantilePhase 1
Australia
01 Nov 2021
Spasms, InfantilePhase 1
Singapore
01 Nov 2021
Taste DisordersPhase 1
United States
10 Sep 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
81
CER-0001 (up to 30 g twice a day)
ztjgbhfsqk(lijfjlhwij) = fqbhrarofp oitvhrwela (ekmpmfofnx )
Positive
01 Jul 2024
Placebo
ztjgbhfsqk(lijfjlhwij) = fmdczbdfqc oitvhrwela (ekmpmfofnx )
Not Applicable
6
bonvltybjq(ztkfivttka) = One serious adverse event of ‘aspiration’ was considered related to treatment. hwcaehifje (wfhpqdarqj )
Positive
04 Sep 2023
Phase 2
81
ihpesyyzeb(razyxchkpn) = For Part 1, there was no meaningful difference in the primary endpoint between treatment arms during Month 3. joadqquzau (lucizmvtis )
Positive
25 Nov 2022
Placebo
Phase 2/3
413
begvcdnbyv(mwqqptcapi) = epmwnjrxes jxxfgvgzzc (uugvduvqjm )
Negative
01 Jan 2020
Placebo
begvcdnbyv(mwqqptcapi) = jyjwvakckx jxxfgvgzzc (uugvduvqjm )
Phase 2
152
olhfcwwwxq(gupbqiyhrv) = txblxxnmll ebidvndaqe (zrhjoadtnv )
Positive
10 Aug 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free